Cite
APA Citation
Müller‐Wieland, D., Kellerer, M., Cypryk, K., Skripova, D., Rohwedder, K., Johnsson, E., Garcia‐Sanchez, R., Kurlyandskaya, R., Sjöström, C. D., Jacob, S., Seufert, J., Dronamraju, N., & Csomós, K. (2018). efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes. Diabetes, obesity & metabolism, 20(11), 2598–2607. http://access.bl.uk/ark:/81055/vdc_100070085670.0x00001c